VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $433,000 | -12.3% | 17,966 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $494,000 | -44.5% | 18,041 | -22.2% | 0.00% | 0.0% |
| Q1 2022 | $890,000 | +12.4% | 23,194 | -6.2% | 0.00% | 0.0% |
| Q4 2021 | $792,000 | +52.6% | 24,737 | +21.5% | 0.00% | 0.0% |
| Q3 2021 | $519,000 | -19.9% | 20,363 | +6.8% | 0.00% | 0.0% |
| Q2 2021 | $648,000 | +0.3% | 19,063 | -4.0% | 0.00% | 0.0% |
| Q1 2021 | $646,000 | -51.6% | 19,858 | -46.5% | 0.00% | 0.0% |
| Q4 2020 | $1,336,000 | +50.6% | 37,119 | +63.8% | 0.00% | -50.0% |
| Q3 2020 | $887,000 | +27.8% | 22,657 | +19.8% | 0.00% | +100.0% |
| Q2 2020 | $694,000 | +155.1% | 18,919 | +60.1% | 0.00% | 0.0% |
| Q1 2020 | $272,000 | -5.2% | 11,819 | +20.5% | 0.00% | 0.0% |
| Q4 2019 | $287,000 | – | 9,812 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |